120
Participants
Start Date
May 4, 2020
Primary Completion Date
November 11, 2020
Study Completion Date
June 21, 2021
BLD-2660
BLD-2660 is a novel, synthetic, orally active, small molecule inhibitor of calpain (CAPN) 1, 2, and 9.
Blade Research Site, Campinas
Blade Research Site, São José do Rio Preto
Blade Research Site, Botucatu
Blade Research Site, Philadelphia
Blade Research Site, Washington D.C.
Blade Research Site, Washington D.C.
Blade Research Site, Baltimore
Blade Research Site, Durham
Blade Research Site, Fayetteville
Blade Research Site, Vitória
Blade Research Site, Charleston
Blade Research Site, Charleston
Blade Research Site, Belo Horizonte
Blade Research Site, Panama City
Blade Research Site, Brandon
Blade Research Site, Tampa
Blade Research Site, Ft. Pierce
Vanderbilt University Medical Center, Nashville
Blade Research Site, Louisville
Blade Research Site, Lexington
Blade Research Site, Bahia
Blade Research Site, Detroit
Blade Research Site, Farmington Hills
Blade Research Site, Ames
Blade Research Site, Peoria
Blade Research Site, Ribeirão Preto
Blade Research Site, Omaha
Blade Research Site, Dallas
Blade Research Site, Porto Velho
Blade Research Site, Idaho Falls
Blade Research Site, Los Angeles
Blade Research Site, Irvine
Blade Reseach Site, San Jose
Blade Research Site, Spokane
Blade Research Site, Ridgewood
Lead Sponsor
Collaborators (1)
Clinipace Worldwide
INDUSTRY
Blade Therapeutics
INDUSTRY